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 ABSTRACT                                                                                                                                            
Triple A syndrome presenting with myopathy: An 
Egyptian patient
Rabah M. Shawky1, Solaf M. Elsayed1 and  Heba H. Elsedfy2
1Genetics and 2Endocrinology clinics, Children’s Hospital, Ain Shams 
University
Triple A syndrome (Allgrove syndrome) is a rare, autosomal recessive disorder 
characterized by Adrenocorticotropic hormone resistant adrenal insuffi ciency, 
Alacrmia, Achalasia of the oesophageal cardia, progressive neurological 
degeneration and occasionally autonomic instability (making it 4A syndrome). 
Reported neurological abnormalities included developmental delay, ataxia and 
polyneuropathy with sensory, motor and autonomic components, long-tract 
degeneration, parkinsonism and mild dementia.
In this paper we report a 13 year old boy with Allgrove syndrome presenting 
with muscular weakness that was confi rmed by EMG studies. To our knowledge, 
muscle disease in Allogrove syndrome was not reported before. 




Allgrove syndrome, triple A syndrome, 
alacrmia, cardiac achalasia, adrenal in-
suffi ciency.
INTRODUCTION                              
Triple A syndrome (Allgrove 
syndrome) is a rare, autosomal 
recessive disorder character-
ized by adrenocorticotrophic 
hormone (ACTH) resistant ad-
renal insuffi ciency, alacrima, 
achalasia of the esophageal 
cardia, progressive neurologi-
cal degeneration and occasion-
ally autonomic instability1. The 
syndrome was fi rst reported by 
Allgrove in 1978 when they de-
scribed two pairs of sibs (3 boys 
and 1 girl) with glucocorticoid 
defi ciency and achalasia of the 
stomach cardia. Three had de-
fective tear formation (alacri-
ma) and one showed other signs 
of autonomic dysfunction.2
The condition is associated with impair-
ment of the central, peripheral and auto-
nomic nervous systems. Progression of 
neurological symptoms has been report-
ed with worsening of peripheral neurop-
athy, dementia, long tract degeneration, 
dysarthria and ataxia3. In this paper we 
report a 13 year old boy with Allgrove 
syndrome presenting with muscular 
weakness that was confi rmed by EMG 
studies. To our knowledge, muscle dis-
ease in Allogrove syndrome was not re-
ported before.
CASE REPORT                                           
A 13 year old boy, seventh in order of 
birth of one and half cousin marriage 
presented to the genetics clinic with a 
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four year history of headache, excessive 
fatigue, diffi culty in walking and climb-
ing the stairs and recurrent fainting at-
tacks. This was accompanied by contin-
uous pain and recurrent ulcers in both 
eyes. One year ago, the patient started 
to have recurrent attacks of vomiting.
On examination, his height was 140 cm 
(-3SD), weight was 28 kg (< - 4 SD). He 
had long thin face, long philtrum, deep 
seated eyes and darker skin than the rest 
of family members especially around 
the lips and knuckles. Chest, heart and 
abdominal examination showed no ab-
normalities (Figures. 1, 2). Neurologi-
cal examination showed wasting, slight 
hypotonia, diminished deep tendon re-
fl exes and weakness of proximal mus-
cles of upper and lower limbs.
Morning cortisol level was 2.7 μg/dl 
(normal level: 4.3- 22.4), ACTH was 
more than 1250 pg/ml (normal level: 
10-60), sodium level was 132 mmol/L 
(normal: 138-145), potassium level was 
5.9 mmol/L (normal:3-5). TSH: 3.94 
μIU /ml (normal: 0. 33-5.5), free T4; 
1.1 ng/dl (0.8-1.9).
Digital computed radiography of bari-
um swallow of the oesophagus showed 
mild gastro-oesophageal refl ux. Oph-
thalmological examination showed 
bilateral alacrmia. EMG studies for 
abductor policies brevis, right biceps, 
and right extensor hallucis brevis 
muscles showed no spontaneous activ-
ity at rest. On mild contraction, motor 
unit action potentials were of small 
amplitude, prolonged duration and oc-
casional polyphasia and early recruit-
ment, with full interference pattern on 
maximum. Nerve conduction velocity 
of both median and right tibial nerves 
revealed normal distal latencies with 
nerve conduction velocity and average 
amplitude for CMAPs. These fi ndings 
were suggestive of a myogenic pattern. 
Audiometry, CT brain and EEG were 
all normal. 
Figs. 1,2: Anteroposterior view of the patient 
showing the darkness around the lip and the 
knuckles.
DISCUSSION                                                   
Neurological abnormalities in Allo-
grove syndrome was fi rst reported by 
Ehrich et al.4 in 1987 in two brothers 
with severe developmental delay, short 
stature, microcephaly, ataxia and op-
tic atrophy4. Furthermore, follow-up 
of the patients originally described by 
Allgrove et al.2 showed that they had 
developed neurologic manifestations, 
including polyneuropathy with senso-
ry, motor and autonomic components, 
long-tract degeneration, parkinsonism, 
and mild dementia3. Although our pa-
tient did not have any of the previous 
107
Shawky et al.
neurological manifestations, he had 
typical symptoms and signs suggestive 
of muscle disease. This was confi rmed 
by electromyogram and nerve conduc-
tion studies.
Muscle weakness could be explained 
by the long-term undiagnosed adrenal 
insuffi ciency which makes a major con-
tribution to reduced motor function and 
quality of life. But unlike other neuro-
logical disorders associated with adre-
nal insuffi ciency, neurological change 
with Allgrove syndrome was reported 
to be extremely slow5. Our patient had 
the onset of muscle weakness very ear-
ly (at the age of nine years) which is 
against the theory of long-term adrenal 
insuffi ciency.
Distinct facial appearance of Allgrove 
syndrome includes long thin face with 
a long philtrum, narrow upper lip, 
down-turned mouth and microcephaly6. 
Except for microcephaly, these features 
were typical to our patient.
Alacrima is the most consistent fea-
ture of this syndrome and is usually 
the earliest manifestation7. This was 
evident in our patient who had persis-
tent complaint of eye pain and redness 
and was not diagnosed with alacramia 
till his presentation to our clinic. Other 
reported ophthalmic manifestations 
include keratoconjunctivitis sicca, 
corneal melts, lacrimal gland atrophy, 
pupillary abnormalities including slug-
gish pupils, tonic pupils with hypersen-
sitivity to dilute miotics, accommoda-
tive dysregulation, amblyopia and optic 
atrophy.1,8
Our patient had both glucocorticoid 
and mineralcorticoid defi ciency. Most 
patients in the literature reported had 
glucocorticoid defi ciency with normal 
mineralocorticoid function, but defi -
ciency has been reported in only 15% 
of patients.9
The orthostatic hypotension that was re-
ported by our patient could be explained 
by abnormal cardiovascular refl exes 
(progressive loss of cholinergic func-
tion) due to autonomic dysfunction.10
Although our patient did not develop 
cardiac achlasia yet, it is known that 
other authors reported Allogrove pa-
tients who had only 2 of the 3 features, 
with variable neurological defects11. 
This was further confi rmed by Prpic et 
al.12 who demonstrated marked pheno-
typic variability in 3 patients with ge-
netically confi rmed triple-A syndrome. 
Two patients had achalasia, alacrima, 
and adrenocortical defi ciency as well as 
neurologic and autonomic dysfunction. 
The third patient had only achalasia and 
neurologic dysfunction. All patients 
were homozygous for mutations in the 
AAAS gene. In the patient with isolated 
achalasia, the diagnosis of triple-A syn-
drome could only be made on the ba-
sis of the molecular genetic analysis of 
the AAAS gene. The authors proposed 
that the diagnosis of triple-A syndrome 
should be made on the basis of molecu-
lar analysis of the AAAS gene and may 
therefore include patients with 1 or 2 of 
the 3 main symptoms.12
Achalasia was also reported to have a 
variable, often insidious presentation. 
Dysphagia may be present for years be-
fore the diagnosis of achalasia is made 
and may be present as gastroesophageal 
refl ux.13
Unlike ACTH resistance syndromes (fa-
milial glucocorticoid defi ciency), triple 
A syndrome is not due to mutations in 
the ACTH receptor, but it has some fea-
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tures of a contiguous gene syndrome10. 
The triple A syndrome is due to muta-
tions in the AAAS gene whose product 
is ALADIN (alacrima-achalasia-adre-
nal insuffi ciency neurologic disorder); 
located on chromosome 12q13.1,8
In conclusion, patients with triple A 
syndrome often reports to a specialist 
with one complaint and the association 
may remain unsuspected, leaving the 
patient prone to complications like Ad-
disonian crisis, recurrent aspiration and 
failure to thrive. All children presenting 
with one of the three symptoms should 
be screened for triple A syndrome. Neu-
rological manifestations of Allogrove 
syndrome may include muscle disease. 
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